A conceptual framework for clinical trials in SLE and other multisystem diseases (Q33777430)

29 July 2017

1 reference

title

A conceptual framework for clinical trials in SLE and other multisystem diseases (English)

1 reference

29 July 2017

M Abrahamowicz

6

0 references

Sang-Cheol Bae

3

object named as

S C Bae

1 reference

29 July 2017

M H Liang

1

1 reference

29 July 2017

M Corzillius

2

1 reference

29 July 2017

P Fortin

4

1 reference

29 July 2017

J M Esdaile

5

1 reference

29 July 2017

language of work or name

1 reference

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

8

1 reference

29 July 2017

570-580

1 reference

29 July 2017

8

1 reference

Scientific and ethical issues in the use of placebo controls in clinical trials

29 July 2017

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Innovative treatment approaches for rheumatoid arthritis. Combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Inherent difficulties with active control equivalence studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Sample size graphs for "proving the null hypothesis".

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Issues in planning and interpreting active control equivalence studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Randomized discontinuation trials: Utility and efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

Time-Dependent Hazard Ratio: Modeling and Hypothesis Testing with Application in Lupus Nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399680411290

10.1191/096120399680411290

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference